Psychoactive Drugs Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
LEXX | D | Lexaria Bioscience Corp. | 0.76 | |
CMPS | D | COMPASS Pathways Plc | 5.20 | |
UVV | F | Universal Corporation | -0.69 | |
YOLO | F | AdvisorShares Pure Cannabis ETF | 1.53 | |
IMCC | F | IM Cannabis Corp | 6.14 | |
MSOS | F | AdvisorShares Pure US Cannabis ETF | 4.38 | |
KTTA | F | Pasithea Therapeutics Corp. | 0.48 | |
INDV | F | Indivior PLC | -0.07 | |
ZVRA | F | Zevra Therapeutics, Inc. | -1.26 | |
AQST | F | Aquestive Therapeutics, Inc. | -0.41 |
Related Industries: Biotechnology Conglomerates Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Care Facilities Packaged Foods Paper & Paper Products Restaurants Tobacco
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PTH | C | Invesco DWA Healthcare Momentum ETF | 0.44 | |
DWAS | C | PowerShares DWA SmallCap Technical Leaders Portfolio | 0.2 | |
IWC | C | iShares Microcap ETF | 0.08 | |
IWM | C | iShares Russell 2000 ETF | 0.02 | |
IWN | C | iShares Russell 2000 Value ETF | 0.01 |
Compare ETFs
- Psychoactive Drugs
A psychoactive drug, psychopharmaceutical, or psychotropic is a chemical substance that changes brain function and results in alterations in perception, mood, consciousness, cognition, or behavior. These substances may be used medically; recreationally; to purposefully improve performance or alter one's consciousness; as entheogens; for ritual, spiritual, or shamanic purposes; or for research. Some categories of psychoactive drugs, which have therapeutic value, are prescribed by physicians and other healthcare practitioners. Examples include anesthetics, analgesics, anticonvulsant and antiparkinsonian drugs as well as medications used to treat neuropsychiatric disorders, such as antidepressants, anxiolytics, antipsychotics, and stimulant medications. Some psychoactive substances may be used in the detoxification and rehabilitation programs for persons dependent on or addicted to other psychoactive drugs.
Psychoactive substances often bring about subjective (although these may be objectively observed) changes in consciousness and mood that the user may find rewarding and pleasant (e.g., euphoria or a sense of relaxation) or advantageous (e.g. increased alertness) and are thus reinforcing. Substances which are both rewarding and positively reinforcing have the potential to induce a state of addiction – compulsive drug use despite negative consequences. In addition, sustained use of some substances may produce physical or psychological dependence or both, associated with somatic or psychological-emotional withdrawal states respectively. Drug rehabilitation attempts to reduce addiction, through a combination of psychotherapy, support groups, and other psychoactive substances. Conversely, certain psychoactive drugs may be so unpleasant that the person will never use the substance again. This is especially true of certain deliriants (e.g. Jimson weed), powerful dissociatives (e.g. Salvia divinorum), and classic psychedelics (e.g. LSD, psilocybin), in the form of a "bad trip".
Psychoactive drug misuse, dependence and addiction have resulted in legal measures and moral debate. Governmental controls on manufacture, supply and prescription attempt to reduce problematic medical drug use. Ethical concerns have also been raised about over-use of these drugs clinically, and about their marketing by manufacturers. Popular campaigns to allow certain recreational drug use (e.g. cannabis) are also ongoing.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles